BioSig Technologies, Inc.
BSGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $40 | $18 | $286 | $441 |
| % Growth | 122.2% | -93.7% | -35.1% | – |
| Cost of Goods Sold | $0 | $0 | $57 | $199 |
| Gross Profit | $40 | $18 | $229 | $242 |
| % Margin | 100% | 100% | 80.1% | 54.9% |
| R&D Expenses | $832 | $5,092 | $5,821 | $5,602 |
| G&A Expenses | $11,629 | $23,077 | $21,380 | $27,853 |
| SG&A Expenses | $11,629 | $23,077 | $21,380 | $27,853 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $441 | $361 | $293 | $198 |
| Operating Expenses | $12,902 | $28,530 | $27,494 | $33,653 |
| Operating Income | -$12,862 | -$28,512 | -$27,265 | -$33,411 |
| % Margin | -32,155% | -158,400% | -9,533.2% | -7,576.2% |
| Other Income/Exp. Net | $2,523 | -$178 | $3 | $555 |
| Pre-Tax Income | -$10,339 | -$28,690 | -$27,262 | -$32,856 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10,330 | -$29,041 | -$27,271 | -$31,362 |
| % Margin | -25,825% | -161,338.9% | -9,535.3% | -7,111.6% |
| EPS | -0.074 | -0.4 | -0.63 | -0.94 |
| % Growth | 81.6% | 36.5% | 33% | – |
| EPS Diluted | -0.074 | -0.4 | -0.63 | -0.94 |
| Weighted Avg Shares Out | 140,417 | 73,518 | 43,072 | 33,512 |
| Weighted Avg Shares Out Dil | 140,417 | 73,518 | 43,072 | 33,512 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $9 | $3 | $2 |
| Interest Expense | $11 | $0 | $0 | $0 |
| Depreciation & Amortization | $188 | $361 | $666 | $639 |
| EBITDA | -$12,421 | -$28,151 | -$26,972 | -$33,213 |
| % Margin | -31,052.5% | -156,394.4% | -9,430.8% | -7,531.3% |